| Product Code: ETC13165011 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Oncology NGS Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Oncology NGS Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Oncology NGS Market - Industry Life Cycle |
3.4 Africa Oncology NGS Market - Porter's Five Forces |
3.5 Africa Oncology NGS Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Africa Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Africa Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.9 Africa Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.10 Africa Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Africa Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Oncology NGS Market Trends |
6 Africa Oncology NGS Market, 2021 - 2031 |
6.1 Africa Oncology NGS Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Oncology NGS Market, Revenues & Volume, By Whole Genome Sequencing, 2021 - 2031 |
6.1.3 Africa Oncology NGS Market, Revenues & Volume, By Whole Exome Sequencing, 2021 - 2031 |
6.2 Africa Oncology NGS Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Oncology NGS Market, Revenues & Volume, By Diagnostics and Screening, 2021 - 2031 |
6.2.3 Africa Oncology NGS Market, Revenues & Volume, By Research Studies, 2021 - 2031 |
6.3 Africa Oncology NGS Market, Revenues & Volume, By Service, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Oncology NGS Market, Revenues & Volume, By Platforms and Related Products, 2021 - 2031 |
6.3.3 Africa Oncology NGS Market, Revenues & Volume, By Services, 2021 - 2031 |
6.4 Africa Oncology NGS Market, Revenues & Volume, By Workflow, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Oncology NGS Market, Revenues & Volume, By Pre-Sequencing, 2021 - 2031 |
6.4.3 Africa Oncology NGS Market, Revenues & Volume, By Sequencing, 2021 - 2031 |
6.4.4 Africa Oncology NGS Market, Revenues & Volume, By NGS Data Analysis, 2021 - 2031 |
6.5 Africa Oncology NGS Market, Revenues & Volume, By End-use, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Africa Oncology NGS Market, Revenues & Volume, By Academic Research, 2021 - 2031 |
6.5.3 Africa Oncology NGS Market, Revenues & Volume, By Clinical Research, 2021 - 2031 |
6.5.4 Africa Oncology NGS Market, Revenues & Volume, By Hospitals & Clinics, 2021 - 2031 |
6.5.5 Africa Oncology NGS Market, Revenues & Volume, By Pharma & Biotech Entities, 2021 - 2031 |
6.5.6 Africa Oncology NGS Market, Revenues & Volume, By Other users, 2021 - 2031 |
7 Africa Oncology NGS Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Oncology NGS Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.1 South Africa Oncology NGS Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.2 Egypt Oncology NGS Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.3 Nigeria Oncology NGS Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.4 Rest of Africa Oncology NGS Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3 Africa Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
7.3.1 South Africa Oncology NGS Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.2 Egypt Oncology NGS Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.3 Nigeria Oncology NGS Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.4 Rest of Africa Oncology NGS Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4 Africa Oncology NGS Market, Revenues & Volume, By Service, 2021 - 2031 |
7.4.1 South Africa Oncology NGS Market, Revenues & Volume, By Service, 2021 - 2031 |
7.4.2 Egypt Oncology NGS Market, Revenues & Volume, By Service, 2021 - 2031 |
7.4.3 Nigeria Oncology NGS Market, Revenues & Volume, By Service, 2021 - 2031 |
7.4.4 Rest of Africa Oncology NGS Market, Revenues & Volume, By Service, 2021 - 2031 |
7.5 Africa Oncology NGS Market, Revenues & Volume, By Workflow, 2021 - 2031 |
7.5.1 South Africa Oncology NGS Market, Revenues & Volume, By Workflow, 2021 - 2031 |
7.5.2 Egypt Oncology NGS Market, Revenues & Volume, By Workflow, 2021 - 2031 |
7.5.3 Nigeria Oncology NGS Market, Revenues & Volume, By Workflow, 2021 - 2031 |
7.5.4 Rest of Africa Oncology NGS Market, Revenues & Volume, By Workflow, 2021 - 2031 |
7.6 Africa Oncology NGS Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.6.1 South Africa Oncology NGS Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.6.2 Egypt Oncology NGS Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.6.3 Nigeria Oncology NGS Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.6.4 Rest of Africa Oncology NGS Market, Revenues & Volume, By End-use, 2021 - 2031 |
8 Africa Oncology NGS Market Key Performance Indicators |
9 Africa Oncology NGS Market - Export/Import By Countries Assessment |
10 Africa Oncology NGS Market - Opportunity Assessment |
10.1 Africa Oncology NGS Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.3 Africa Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
10.4 Africa Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
10.5 Africa Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
10.6 Africa Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
11 Africa Oncology NGS Market - Competitive Landscape |
11.1 Africa Oncology NGS Market Revenue Share, By Companies, 2022 |
11.2 Africa Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here